H
TEVA icon

Hexavest’s Teva Pharmaceuticals TEVA Stock Holding History

Hexavest’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-6,775
Closed -$104K – 429
2018
Q4 		$104K Buy
+6,775
New +$139K ﹤0.01% 263
2017
Q4 		– Sell
-319,710
Closed -$5.63M – 492
2017
Q3 		$5.63M Sell
319,710
-2,522
-0.8% -$56.7K 0.07% 188
2017
Q2 		$10.7M Buy
322,232
+1,198
+0.4% +$37.1K 0.14% 150
2017
Q1 		$10.3M Buy
321,034
+310,215
+2,867% +$10.6M 0.12% 153
2016
Q4 		$392K Buy
10,819
+1,715
+19% +$68.5K 0.01% 257
2016
Q3 		$419K Sell
9,104
-2,850
-24% -$149K 0.01% 263
2016
Q2 		$600K Sell
11,954
-3,679
-24% -$196K 0.01% 270
2016
Q1 		$837K Sell
15,633
-725
-4% -$42.5K 0.01% 250
2015
Q4 		$1.07M Buy
16,358
+4,280
+35% +$264K 0.02% 235
2015
Q3 		$682K Sell
12,078
-968
-7% -$62.8K 0.01% 242
2015
Q2 		$771K Hold
13,046
– – 0.01% 250
2015
Q1 		$813K Hold
13,046
– – 0.01% 232
2014
Q4 		$750K Sell
13,046
-8,550
-40% -$476K 0.01% 233
2014
Q3 		$1.16M Hold
21,596
– – 0.02% 232
2014
Q2 		$1.13M Buy
21,596
+945
+5% +$48.3K 0.02% 229
2014
Q1 		$1.09M Buy
20,651
+10,400
+101% +$481K 0.02% 222
2013
Q4 		$411K Sell
10,251
-200
-2% -$7.88K 0.01% 265
2013
Q3 		$395K Buy
10,451
+7,000
+203% +$273K 0.01% 272
2013
Q2 		$135K Buy
+3,451
New +$134K ﹤0.01% 298

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hexavest's TEVA Position: Q1 2019 in Review

Hexavest sold out of Teva Pharmaceuticals (TEVA) in Q1 2019, closing a stake of 6,775 shares — an estimated $104K sold.

Hexavest first reported a position in TEVA in Q2 2013 and held it in 19 quarters. The position peaked at $10.7M in Q2 2017. 522 funds tracked by Wall St. Rank hold TEVA as of Q1 2019.

  • Hexavest reported no remaining Teva Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Hexavest sold 6,775 Teva Pharmaceuticals shares in Q1 2019, an estimated $104K.
  • Hexavest first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 19 quarters.
  • Hexavest's Teva Pharmaceuticals position peaked at $10.7M in Q2 2017.
  • 522 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2019.

Based on Hexavest's 13F filing for Q1 2019, filed 9 Apr 2019.